Problems of Radiation Medicine and Radiobiology

S. M. Kozhukhov, О. Ye. Bazyka, N. V. Dovganych, О. A. Yarynkina, N. V. Tkhor

SI «National Research Center «The Academician M. D. Strazhesko Institute of Cardiology» of the NAMS of Ukraine», 5 Narodnoho Opolchennia St., Kyiv, 03680, Ukraine

RADIOTHERAPY-ASSOCIATED CARDIOVASCULAR COMPLICATIONS IN CANCER (review)

The review is devoted to the current issues of radiation-induced cardiovascular complications, their diagnostics and incidence depending on the radiation doses and exposure regimens, potential efficiency of the screening strategies for cardiotoxicity monitoring after radiotherapy in cancer patients by analyzing the data from literature and clinical trials, based on recommendations of European Society of Cardiology and European Society of Medical Oncology.
Key words: cardiovascular complications, radiation therapy.

Problems of Radiation Medicine and Radiobiology.
2020;25:56-74. doi: 10.33145/2304-8336-2020-25-56-74

full text

1. Zamorano JL, Lancellotti P, Muñoz DR, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) [published correction appears in Eur Heart J. 2016 Dec 24] Eur Heart J. 2016;37(36):2768-2801. doi:10.1093/eurheartj/ehw211.
2. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van’t Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-speci?c mortality of patients treated for Hodgkin’s disease. J Clin Oncol. 2003;21(18):3431-3439. doi:10.1200/JCO.2003.07.131.
3. Ng AK. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma. Br J Haematol. 2011;154(1):23-31. doi: 10.1111/j.1365-2141.2011.08713.x.
4. Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64. doi: 10.1186/bcr2901.
5. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007;99(3):206-214. DOI: 10.1093/jnci/djk029.
6. Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze JA, Goodman P, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2011;117(6):1806-1816. doi: 10.1182/blood-2010-04-278796.
7. Yeoh KW, Mikhaeel NG. Role of radiotherapy in modern treatment of Hodgkin’s lymphoma. Adv Hematol. 2011;2011:258797. doi: 10.1155/2011/258797.
8. Wethal T, Lund MB, Edvardsen T, Fosså SD, Pripp AH, Holte H, et al. Valvular dysfunction and left ventricular changes in Hodgkin’s lymphoma survivors. A longitudinal study. Br J Cancer. 2009;101(4):575-581. doi: 10.1038/sj.bjc.6605191.
9. Bauer K, Herbst C, Brillant C, Monsef I, Kluge S, Skoetz N, Engert A. Eleventh biannual report of the Cochrane Haematological Malignancies Group: focus on Hodgkin lymphoma. J Natl Cancer Inst. 2010;102(12)E1. doi: 10.1093/jnci/djq188.
10. Paiva PF, Soares AA, Pinheiro GS, Paiva CF, Fabri GMC, Paiva EG, et al. Heart valve injury induced by mediastinum radiotherapy in cancer treatment. J Pharm Pharmac. 2018;6(6):578-586. DOI:10.17265/2328-2150/2018.06.004.
11. Ferme C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, et al. Chemotherapy plus involved-?eld radiation in early-stage Hodgkin’s disease. N Engl J Med. 2007;357(19)1916-1927. doi: 10.1056/NEJMoa064601.
12. van Rijswijk S, Huijbregts MA, Lust E, Strack van Schijndel RJ. Mini-review on cardiac complications after mediastinal irradiation for Hodgkin lymphoma. Neth J Med. 2008;66(6)234-237.
13. Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, LaCasce A, et al.Clinically signi?cant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011;117(2):412-418. doi: 10.1182/blood-2010-06-291328.
14. Cuomo JR, Sharma GK, Conger PD, Weintraub NL. Novel concepts in radiation-induced cardiovascular disease. World J Cardiol. 2016;8(9):504-519. doi: 10.4330/wjc.v8.i9.504.
15. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25(25):3991-4008. doi: 10.1200/JCO.2007.10.9777.
16. National Breast Cancer Foundation. 2013. Available at: http://www. nbcf.org.au/Research/About-Breast-Cancer.aspx. Accessed December 21, 2012. (cited 20.01.2020)
17. Early Breast Cancer Trialists’ Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000;355(9217):1757-1770.
18. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087-2006. doi: 10.1016/S0140-6736(05)67887-7.
19. Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99(5):365-375. doi: 10.1093/jnci/djk064.
20. Correa CR, Litt HI, Hwang WT, Ferrari VA, Solin LJ, Harris EE. Coronary artery ?ndings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol. 2007;25(21):3031-3037. doi: 10.1200/JCO.2006.08.6595.
21. Bouillon K, Haddy N, Delaloge S, Garbay JR, Garsi JP, Brindel P, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011;57(4):445-452. doi: 10.1016/j.jacc.2010.08.638.
22. Stewart MH, Jahangir E, Polin NM. Valvular heart disease in cancer patients: etiology, diagnosis,and management. Curr Treat Options Cardiovasc Med. 2017;19(7):53. doi: 10.1007/s11936-017-0550-6.
23. Eichenauer DA, Engert A, Dreyling M. Hodgkin’s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;21(Suppl 6):vi55-58. doi: 10.1093/annonc/mdr378.
24. Hodgson DC. Late effects in the era of modern therapy for Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2011;2011:323-329. doi: 10.1182/asheducation-2011.1.323.
25. Schellong G, Riepenhausen M, Bruch C, Kotthoff S, Vogt J, Bolling T, et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longi- tudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer. 2010;55(6):1145-1152. doi: 10.1002/pbc.22664.
26. Hatoum OA, Otterson MF, Kopelman D, Miura H, Sukhotnik I, Larsen BT, et al. Radiation induces endothelial dysfunction in murine intestinal arterioles via enhanced production of reactive oxygen species. Arterioscler Thromb Vasc Biol. 2006;26(2):287-294. doi: 10.1161/01.ATV.0000198399.40584.8c.
27. Gaya AM, Ashford RF. Cardiac complications of radiation therapy. Clin Oncol. (R Coll Radiol) 2005;17(3):153-159. doi: 10.1016/j.clon.2004.09.016.
28. Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, et al. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys. 2010;76(3):656-665. doi: 10.1016/j.ijrobp.2009.09.064.
29. Ng AK, Abramson JS, Digumarthy SR, Reingold JS, Stone JR. Case records of the Massachusetts General Hospital. Case 24-2010. A 56-year-old woman with a history of Hodgkin’s lymphoma and sudden onset of dyspnea and shock. N Engl J Med. 2010;363(7)664-675. doi: 10.1056/NEJMcpc1004087.
30. Lenihan DJ, Cardinale DM. Late cardiac effects of cancer treatment. J Clin Oncol. 2012;30(30):3657-3664. doi: 10.1200/JCO.2012.45.2938.
31. Boerma M, Kruse JJ, van Loenen M, Klein HR, Bart CI, Zurcher C, Wondergem J. Increased deposition of von Willebrand factor in the rat heart after local ionizing irradiation. Strahlenther Onkol. 2004;180(2)109-116. doi: 10.1007/s00066-004-1138-0.
32. Apter S, Shemesh J, Raanani P, Portnoy O, Thaler M, Zissin R, et al. Cardiovascular calci?cations after radiation therapy for Hodgkin lymphoma: computed tomography detection and clinical correlation. Coron Artery Dis. 2006;17(2):145-151. doi: 10.1097/00019501-200603000-00008.
33. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290(21):2831-2837. doi: 10.1001/jama.290.21.2831.
34. Heidenreich PA, Kapoor JR. Radiation induced heart disease: systemic disorders in heart disease. Heart. 2009;95(3)252-258. doi: 10.1136/hrt.2008.149088.
35. Nellessen U, Zingel M, Hecker H, Bahnsen J, Borschke D. Effects of radiation therapy on myocardial cell integrity and pump function: which role for cardiac biomarkers? Chemotherapy. 2010;56(2):147-152. doi: 10.1159/000313528.
36. Heidenreich PA, Hancock SL, Vagelos RH, Lee BK, Schnittger I. Diastolic dysfunction after mediastinal irradiation. Am Heart J. 2005;150(5):977-982. doi: 10.1016/j.ahj.2004.12.026.
37. Marliere S, Vautrin E, Saunier C, Chaikh A, Gabelle-Flandin I. [Radiation-related heart toxicity: update in women]. Ann Cardiol Angeiol (Paris) 2016;65(6):411-419. doi: 10.1016/j.ancard.2016.10.012. French.
38. Bijl JM, Roos MM, van Leeuwen-Segarceanu EM, Bos WW, Biesma DH, Post MC. Assessment of valvular disorders in survivors of Hodgkin’s lymphoma treated by mediastinal radiotherapy ± chemotherapy. Am J Cardiol. 2016;117(4):691-696. doi: 10.1016/j.amjcard.2015.11.027.
39. Crestanello JA, McGregor CG, Danielson GK, Daly RC, Dearani JA, Orszulak TA, et al. Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy. Ann Thorac Surg. 2004;78(3):826–831. doi: 10.1016/j.athoracsur.2004.04.008.
40. Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am College Cardiology. 2013;61(23):2319-2328. doi: 10.1016/j.jacc.2013.01.090.
41. van Dalen EC, van der Pal HJ, van den Bos C, Kok WE, Caron HN, Kremer LC. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer. 2006;42(15):2549-2553. doi: 10.1016/j.ejca.2006.04.014.
42. Murbraech K, Wethal T, Smeland KB, Holte H, Loge JH, Holte E, et al. Valvular dysfunction in lymphoma survivors treated with autologous stem cell transplantation: A National Cross-Sectional Study. JACC Cardiovasc Imaging. 2016;9(3):230-239. doi: 10.1016/j.jcmg.2015.06.028.
43. Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, Davin L, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2013;14(8):721-740. doi: 10.1093/ehjci/jet123.
44. Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, et al. Survivorship, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(10):1216–1247. doi: 10.6004/jnccn.2018.0078
45. Iles L, P?uger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011;57(7):821-828. doi: 10.1016/j.jacc.2010.06.062.
46. Ng AC, Auger D, Delgado V, van Elderen SG, Bertini M, Siebelink HM, et al. Association between diffuse myocardial ?brosis by cardiac magnetic resonance contrast-enhanced T1 mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study. Circ Cardiovasc Imaging. 2012;5(1):51-59. doi: 10.1161/CIRCIMAGING.111.965608.
47. Schomig K, Ndrepepa G, Mehilli J, Pache J, Kastrati A, Schomig A. Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement. Catheter Cardiovasc Interv. 2007;70(3):359-365. doi: 10.1002/ccd.21109.
48. Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: a clinical update. Cardiol Res Pract. 2011;2011:317659. doi: 10.4061/2011/317659.
49. Chang AS, Smedira NG, Chang CL, Benavides MM, Myhre U, Feng J, et al. Cardiac surgery after mediastinal radiation: extent of exposure in?uences outcome. J Thorac Cardiovasc Surg. 2007;133(2):404-413. doi: 10.1016/j.jtcvs.2006.09.041.
50. Siregar S, de Heer F, van Herwerden LA. Cardiac surgery in patients irradiated for Hodgkin’s lymphoma. Neth Heart J. 2010;18(2):61-65. doi: 10.1007/BF03091739.
51. Durham SJ, Gold JP. Late complications of cardiac surgery. New York, NY : McGraw Hill, 2008.
52. Poulin F, Semionov A, Romeo P, Demers P, Pressacco J, Basmadjian A. Extensive radiation-induced heart disease in an adult patient treated for lymphoma as a child. Can J Cardiol. 2011;27(3):390.e1-4. doi: 10.1016/j.cjca.2010.12.048.
53. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53(15):e1-e90. doi: 10.1016/j.jacc.2008.11.013.
54. Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, Stahrenberg R, et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol. 2011;58:1780-1791. doi: 10.1016/j.jacc.2011.06.054.
55. Uriel N, Vainrib A, Jorde UP, Cotarlan V, Farr M, Cheema FH, et al. Mediastinal radiation and adverse outcomes after heart transplantation. J Heart Lung Transplant. 2010;29(3):378-381. doi: 10.1016/j.healun.2009.08.011.